BUY IPCA Laboratories Limited — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))17 Aug 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Krebs Biochemicals narrows Q1FY26 net loss 53% on revenue surge
NewsGoogle News·6 Aug · 1w ago
Krebs Biochemicals का Ipca Labs के साथ मर्जर मंजूर, नेट लॉस में आई कमी
NewsGoogle News·6 Aug · 1w ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·10 Jul · 1mo ago
IPCA Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·13 Aug · 3d ago
Standalone and Consolidated Unaudited Financial Results for Q1FY27
BSE · Board Meeting·13 Aug · 3d ago
Lyka Labs Limited Passes All Five Resolutions at 47th Annual General Meeting
NewsGoogle News·11 Aug · 5d ago
Ipca Laboratories Share: ફાર્મા કંપનીના શેરમાં **2%**નો ઘટાડો, જાણો કારણ અને આગામી ડેટ્સ
NewsGoogle News·6 Aug · 1w ago
Ipca Laboratories Share Price: मिडकैप इंडेक्स में गिरावट का असर, स्टॉक **2%** फिसला
NewsGoogle News·6 Aug · 1w ago
Ipca Laboratories Shares: ਮਾਰਕੀਟ 'ਚ ਗਿਰਾਵਟ, ਸ਼ੇਅਰ **2%** ਡਿੱਗਿਆ
NewsGoogle News·6 Aug · 1w ago
Krebs Biochemicals & Industries: Ipca Labs உடன் இணைப்புக்கு ஒப்புதல்! நஷ்டம் குறைவு, ஆனால் சிக்கல் தொடர்கிறது
NewsGoogle News·6 Aug · 1w ago
Krebs Biochemicals & Industries: Ipca తో విలీనం ఖరారు.. లాస్ తగ్గినా ప్లాంట్ మూతతో కష్టాలు!
NewsGoogle News·6 Aug · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on IPCA Laboratories
- BUY — Vikas Sethi, Sethi Finmart23 Oct 2026 · ~1 year · target ₹2,250 · Active
- BUY — Kunal Saraogi23 Oct 2026 · ~3 months · target ₹2,350 · Active
- BUY — Manas Jaiswal22 Oct 2026 · ~2 weeks · target ₹2,000 · Active
- BUY — Vikas Sethi, Sethi Finmart8 Oct 2026 · ~1 year · target ₹2,300 · SL hit
- BUY — Sudeep Shah, SBICAP Securities5 Oct 2026 · ~3 months · target ₹2,040 · SL hit
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

